Altered bile acid profile associates with cognitive impairment in Alzheimer's disease—An emerging role for gut microbiome
Siamak MahmoudianDehkordi(Duke University), Rima Kaddurah‐Daouk(Duke University), David A. Bennett(Rush University Medical Center), Alexandra Kueider‐Paisley(Duke University), Cornelia M. van Duijn(University of Oxford), Shannon L. Risacher(Indiana University School of Medicine), Lisa St John Williams(Abterra Biosciences (United States)), John Q. Trojanowski(University of Pennsylvania), Gregory Louie(Duke University), Andrew J. Saykin(Alzheimer’s Disease Neuroimaging Initiative), Rebecca Baillie(Rosa (United States)), Simon Schafferer(Biocrates Life Sciences (Austria)), Philip L. De Jager(Broad Institute), Therese Koal(Biocrates Life Sciences (Austria)), Guoxiang Xie(Ningbo University), Jessica D. Tenenbaum(Duke University), Alison A. Motsinger‐Reif(North Carolina State University), Sudeepa Bhattacharyya(Arkansas State University), Daniel M. Rotroff(North Carolina State University), Jon B. Toledo(Methodist Hospital), Gabi Kastenmüller(Queen Mary University of London), Matthias Arnold(Duke University), Thomas Hankemeier(Centre for Human Drug Research), M. Arthur Moseley(Abterra Biosciences (United States)), John Jack(North Carolina State University), Kwangsik Nho(Indiana University School of Medicine), Wei Jia(Sichuan University), Paul M. Thompson(University of Southern California), Xianlin Han(The University of Texas at San Antonio Health Science Center), Shahzad Ahmad(University of Veterinary and Animal Sciences), Leslie M. Shaw(California University of Pennsylvania), Michael W. Weiner(University of California, San Francisco), Mitchel A. Kling(Philadelphia VA Medical Center), Colette Blach(Duke University), P. Murali Doraiswamy(Alzheimer’s Disease Neuroimaging Initiative), Sebastian Klein(Biocrates Life Sciences (Austria))
Cited by 690
Related Papers
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|7.1k
Proposed minimum reporting standards for chemical analysis
|Metabolomics|2007|5k
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k
National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease
|Alzheimer s & Dementia|2012|3.2k